A detailed history of Degroof Petercam Asset Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Degroof Petercam Asset Management holds 131,681 shares of LLY stock, worth $98.8 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
131,681
Previous 128,911 2.15%
Holding current value
$98.8 Million
Previous $75.1 Billion 36.33%
% of portfolio
1.23%
Previous 0.99%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $1.64 Million - $2.19 Million
2,770 Added 2.15%
131,681 $102 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $67.7 Million - $79.8 Million
128,911 New
128,911 $75.1 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Degroof Petercam Asset Management Portfolio

Follow Degroof Petercam Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Degroof Petercam Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Degroof Petercam Asset Management with notifications on news.